X 
Financials Ratios
Home | Market Info | Company Profile | Financials Ratios
Aspira Pathlab & Diagnostics Ltd.
BSE CODE: 540788   |   NSE CODE: NA   |   ISIN CODE : INE500C01017   |   13-Mar-2026 Hrs IST
BSE NSE
Rs. 60.16
5.16 ( 9.38% )
 
Prev Close ( Rs.)
55.00
Open ( Rs.)
60.50
 
High ( Rs.)
60.50
Low ( Rs.)
55.10
 
Volume
70
Week Avg.Volume
NA
 
52 WK High-Low Range(Rs.)
BSE NSE
Rs.
( )
 
Prev Close ( Rs.)
Open ( Rs.)
 
High ( Rs.)
Low ( Rs.)
 
Volume
Week Avg.Volume
NA
 
52 WK High-Low Range(Rs.)
Particulars Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Operational & Financial Ratios          
   Earnings Per Share (Rs)2.01  -2.60  -0.09  4.33  1.34  
   CEPS(Rs)3.46  -1.10  1.45  5.92  2.75  
   DPS(Rs)0.00  0.00  0.00  0.00  0.00  
   Book NAV/Share(Rs)11.87  9.85  12.39  12.43  8.08  
   Tax Rate(%)0.00  0.00  0.00  0.00  0.00  
Margin Ratios          
   Core EBITDA Margin(%)16.02  -8.99  11.02  32.32  23.11  
   EBIT Margin(%)11.00  -17.45  2.27  24.73  14.95  
   Pre Tax Margin(%)9.42  -20.24  -0.61  22.82  9.08  
   PAT Margin (%)9.42  -20.24  -0.61  22.82  9.08  
   Cash Profit Margin (%)16.21  -8.58  10.35  31.19  18.58  
Performance Ratios          
   ROA(%)12.86  -16.67  -0.50  29.82  10.58  
   ROE(%)18.54  -23.34  -0.69  42.26  22.80  
   ROCE(%)19.64  -18.49  2.40  41.63  21.52  
   Asset Turnover(x)1.37  0.82  0.81  1.31  1.16  
   Sales/Fixed Asset(x)1.24  0.77  0.86  1.29  1.16  
   Working Capital/Sales(x)7.35  5.78  3.38  3.65  8.14  
Efficiency Ratios          
   Fixed Capital/Sales(x)0.81  1.29  1.17  0.77  0.87  
   Receivable days38.11  63.31  86.22  57.84  27.69  
   Inventory Days7.95  11.69  10.14  7.20  7.72  
   Payable days72.32  74.56  69.77  74.12  73.86  
Valuation Parameters          
   PER(x)42.33  0.00  0.00  14.96  21.24  
   PCE(x)24.60  -28.15  19.15  10.94  10.38  
   Price/Book(x)7.18  3.15  2.25  5.22  3.53  
   Yield(%)0.00  0.00  0.00  0.00  0.00  
   EV/Net Sales(x)3.95  2.39  1.89  3.37  1.93  
   EV/Core EBITDA(x)22.18  -41.27  14.25  10.19  7.91  
   EV/EBIT(x)35.86  -13.71  83.04  13.64  12.94  
   EV/CE(x)6.47  2.82  1.99  3.63  2.50  
   M Cap / Sales3.99  2.42  1.98  3.41  1.93  
Growth Ratio          
   Net Sales Growth(%)66.60  -8.66  -26.02  28.52  80.66  
   Core EBITDA Growth(%)611.07  -140.01  -70.41  74.00  341.42  
   EBIT Growth(%)205.01  -801.52  -93.20  112.63  171.01  
   PAT Growth(%)177.56  -2912.63  -101.99  222.91  132.57  
   EPS Growth(%)177.56  -2911.72  -101.99  222.91  129.40  
Financial Stability Ratios          
   Total Debt/Equity(x)0.10  0.11  0.08  0.07  0.15  
   Current Ratio(x)2.26  2.10  3.70  3.99  1.93  
   Quick Ratio(x)2.05  1.89  3.44  3.77  1.75  
   Interest Cover(x)6.97  -6.27  0.79  12.97  2.55  
   Total Debt/Mcap(x)0.01  0.03  0.03  0.01  0.04